Skip to content

Stimulation of the Diaphragm in Patients With Severe Heart Failure Following Heart Surgery

Biventricular Pacing and Stimulation of the Diaphragm in Patients With Severe Heart Failure Following Heart Surgery (Epiphrenic II Pilot Trial)

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT00769678
Enrollment
33
Registered
2008-10-09
Start date
2008-10-31
Completion date
Unknown
Last updated
2013-04-17

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Heart Failure

Keywords

Biventricular Pacing

Brief summary

This study examines whether a permanent stimulation of the diaphragm improves left ventricular function in patients with severe heart failure following heart surgery.

Detailed description

Previous studies have shown that temporary stimulation of the diaphragm using an electrode to the phrenic nerve reduces electrical mechanical activation time (EMAT) and improves left ventricular function. This study examines whether patients with severe heart failure, who require permanent biventricular pacing after heart surgery, may benefit from an additional permanent electrode that stimulates the diaphragm. Heart function is assessed by echocardiography and acoustic cardiography (Audicor, Inovise Medical Inc., Portland, USA).

Interventions

DEVICEStimulation of the diaphragm

Stimulation of the diaphragm using an electrode

Sponsors

Inovise Medical
CollaboratorINDUSTRY
Luzerner Kantonsspital
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
CROSSOVER
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Patients following open heart surgery who need permanent pacing

Exclusion criteria

* Patients with fast changing need of vasopressors

Design outcomes

Primary

MeasureTime frame
Left ventricular ejection fractionOne day

Secondary

MeasureTime frame
Brain natriuretic peptide (BNP)One day
6-minutes walking distanceOne day
NYHA functional classOne day

Countries

Switzerland

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Mar 10, 2026